<SEC-DOCUMENT>0000921895-25-002032.txt : 20250728
<SEC-HEADER>0000921895-25-002032.hdr.sgml : 20250728
<ACCEPTANCE-DATETIME>20250728192002
ACCESSION NUMBER:		0000921895-25-002032
CONFORMED SUBMISSION TYPE:	144
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20250728
DATE AS OF CHANGE:		20250728

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MEI Pharma, Inc.
		CENTRAL INDEX KEY:			0001262104
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				510407811
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		144
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	001-41827
		FILM NUMBER:		251157066

	BUSINESS ADDRESS:	
		STREET 1:		9920 PACIFIC HEIGHTS BLVD
		STREET 2:		SUITE 150
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		858-369-7100

	MAIL ADDRESS:	
		STREET 1:		9920 PACIFIC HEIGHTS BLVD
		STREET 2:		SUITE 150
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MARSHALL EDWARDS INC
		DATE OF NAME CHANGE:	20030902

REPORTING-OWNER:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Anson Funds Management LP
		CENTRAL INDEX KEY:			0001491072
		ORGANIZATION NAME:           	
		EIN:				300134498
		STATE OF INCORPORATION:			TX
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		144

	BUSINESS ADDRESS:	
		STREET 1:		16000 DALLAS PARKWAY
		STREET 2:		SUITE 800
		CITY:			DALLAS
		STATE:			TX
		ZIP:			75248
		BUSINESS PHONE:		214.866.0202

	MAIL ADDRESS:	
		STREET 1:		16000 DALLAS PARKWAY
		STREET 2:		SUITE 800
		CITY:			DALLAS
		STATE:			TX
		ZIP:			75248

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Frigate Ventures LP
		DATE OF NAME CHANGE:	20100504
</SEC-HEADER>
<DOCUMENT>
<TYPE>144
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>144</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001491072</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <issuerInfo>
      <issuerCik>0001262104</issuerCik>
      <issuerName>MEI Pharma, Inc.</issuerName>
      <secFileNumber>001-41827</secFileNumber>
      <issuerAddress>
        <com:street1>9920 Pacific Heights Blvd., Suite 150</com:street1>
        <com:city>San Diego</com:city>
        <com:stateOrCountry>CA</com:stateOrCountry>
        <com:zipCode>92121</com:zipCode>
      </issuerAddress>
      <issuerContactPhone>858-369-7100</issuerContactPhone>
      <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Anson Funds Management LP</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
      <relationshipsToIssuer>
        <relationshipToIssuer>Former 10% Stockholder</relationshipToIssuer>
      </relationshipsToIssuer>
    </issuerInfo>
    <securitiesInformation>
      <securitiesClassTitle>Common Stock</securitiesClassTitle>
      <brokerOrMarketmakerDetails>
        <name>Mint Brokers Holding I, LLC</name>
        <address>
          <com:street1>55 Water Street, 10th Floor</com:street1>
          <com:city>New York</com:city>
          <com:stateOrCountry>NY</com:stateOrCountry>
          <com:zipCode>10041</com:zipCode>
        </address>
      </brokerOrMarketmakerDetails>
      <noOfUnitsSold>1093184</noOfUnitsSold>
      <aggregateMarketValue>7368087.00</aggregateMarketValue>
      <noOfUnitsOutstanding>29879755</noOfUnitsOutstanding>
      <approxSaleDate>07/28/2025</approxSaleDate>
      <securitiesExchangeName>NASDAQ</securitiesExchangeName>
    </securitiesInformation>
    <securitiesToBeSold>
      <securitiesClassTitle>Common Stock</securitiesClassTitle>
      <acquiredDate>11/20/2021</acquiredDate>
      <natureOfAcquisitionTransaction>Open Market Purchase(1)</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Open Market Purchase(1)</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>1093184</amountOfSecuritiesAcquired>
      <paymentDate>11/30/2021</paymentDate>
      <natureOfPayment>Cash</natureOfPayment>
    </securitiesToBeSold>
    <nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
    <remarks>(1) The Aggregate Market Value is as of the close of business on 07/25/2025. The number of securities outstanding is as of 07/22/2025. The approximate date of sale is 07/28/2025 through 10/26/2025. Shares of Common Stock to be sold were purchased by entities co-managed by Anson Funds Management LP between 11/30/2021 and 09/22/2023 in various open market transactions.</remarks>
    <noticeSignature>
      <noticeDate>07/28/2025</noticeDate>
      <signature>Tony Moore, Authorized Signatory of Anson Funds Management LP</signature>
    </noticeSignature>
  </formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
